Scanway S.A.
Company Overview
Scanway S.A. is a Polish observation-technology company operating at the intersection of optics, electronics and software. Its principal business is designing and producing optical payloads for satellites and other space applications, including Earth-observation telescopes, inspection cameras and onboard image-processing systems. Scanway also develops machine-vision systems for industrial quality control. The two businesses share optical technology, software, spectral-imaging expertise and image-processing intellectual property. The Group consists of Scanway S.A. and its wholly owned US subsidiary, Scanway Space Corporation, which was established to support commercial development in the US market.
Business Segments
- Space: optical payloads and telescopes for Earth-observation satellites, lunar missions and other remote-sensing applications
- Space camera systems: compact cameras and electronic subsystems used to inspect satellites, deployment processes and other in-space operations
- Optical-data processing: onboard and ground-based software for image acquisition, processing, analytics and, eventually, event prediction
- Industry: machine-vision systems used for automated quality and process control on production lines
- HYDRA platform: modular image-processing and machine-learning software combining reusable core technology with customer-specific application and integration modules
Key Drivers
- Conversion of the PLN 53.52 million backlog into revenue, with the overwhelming majority attributable to the Space segment
- Successful delivery of constellation projects that may generate repeat orders for multiple satellites
- Expansion from small optical payloads into larger telescopes capable of achieving sub-one-metre Earth-observation resolution
- Growth in European defence, dual-use and sovereign Earth-observation expenditure
- Execution of projects for customers and partners including ESA, Intuitive Machines, Nara Space Technology, Marble Imaging and clients in Asia and the United States
- Commercialisation of lunar and deep-space instruments, including potential follow-on missions
- Increasing annual production capacity toward several or more than ten optical payloads
- Successful scaling of laboratories, clean-room, integration, calibration and testing capabilities
- Development of HYDRA into a repeatable software platform with shorter implementation times and a greater recurring-revenue component
- Transfer of common optical and image-processing technology between the Space and Industry businesses
- Flight heritage and successful operation of Scanway instruments in orbit, improving credibility in future tenders
- Ability to recruit and retain specialised optical, electronics, FPGA, software and machine-learning engineers
Key Risks
- Revenue is project-based, milestone-driven and may be highly volatile between quarters
- The current backlog is heavily concentrated in the Space segment, while the Industry segment remains comparatively small
- Large space projects may be delayed by customer schedules, satellite-platform development, regulatory approvals or launch availability
- A launch failure or an instrument malfunction in orbit could damage Scanway's reputation and reduce its chances of receiving follow-on orders
- Scaling production from bespoke instruments to serial manufacturing may create quality, delivery and cost-control problems
- Operating costs and working-capital requirements may rise before related project milestones are invoiced and collected
- Dependence on specialised components and subcontractors may expose the company to supply shortages, long lead times and price increases
- Contracts may require significant expenditure on materials and engineering before milestone payments are received
- Customer and contract concentration means that the delay or cancellation of one major project could materially affect results
- Competition from larger European and international optical-system suppliers may limit Scanway's participation in commercial constellations
- The forum discussion highlighted uncertainty over Marble Imaging's selection of Safran as an additional telescope supplier, illustrating the risk that development cooperation does not automatically translate into serial orders
- The Group remains loss-making while expanding employment, infrastructure and production capacity
- Rapid growth may require additional equity or debt financing and could result in shareholder dilution
- A substantial portion of the balance sheet consists of capitalised development costs and intangible assets whose recoverability depends on future commercialisation
- Long-duration international contracts create foreign-exchange, geopolitical, export-control and contractual-enforcement risks
What to Watch
- Quarterly revenue recognition relative to project milestones and the seasonality of contract settlements
- Backlog growth, composition and conversion into revenue during 2026 and 2027
- The value of projects awaiting formalisation compared with legally signed backlog
- Space revenue concentration and progress in rebuilding the Industry segment's contribution
- Delivery and launch schedules for Nara Space, Marble Imaging, Intuitive Machines, CAMILA and other constellation projects
- Successful commissioning and calibration of PIAST instruments already in orbit
- Follow-on decisions and contract values related to the Mani lunar mission and additional Intuitive Machines payloads
- Progress in producing the approximately 450 mm telescope developed through the SEMOViS project
- Number of instruments in production, delivered and successfully operating in space
- Expansion of production, clean-room, integration and calibration capacity
- Operating expenses, headcount growth and the point at which revenue growth begins to produce positive EBITDA
- Cash consumption after the fall in cash from PLN 25.52 million at year-end 2025 to PLN 13.48 million at the end of Q1 2026
- Working-capital movements caused by material purchases and work performed ahead of milestone payments
- New equity authorisations, capital increases or other financing needed to support contracts larger than the current balance sheet
- Commercial adoption of HYDRA and evidence of shorter implementation times, repeatability and recurring software revenue
- Customer diversification across Europe, Asia, the United States and other markets
- Progress toward becoming a serial producer of optical payloads rather than a primarily bespoke engineering contractor
Foundational Analysis
Business Model
Scanway designs optical instruments and related electronics and software for customers carrying out satellite, lunar and other space missions. Contracts are generally customised, technically complex and completed over multiple reporting periods. Revenue is recognised either over time according to project progress or when control of the completed product is transferred, depending on the contract. Consequently, reported revenue depends on engineering progress, customer acceptance and contractual milestones rather than on evenly distributed product shipments. The Space business sells telescopes, cameras, optical payloads, engineering work and image-processing systems. The Industry business designs and deploys machine-vision systems used to inspect products and manufacturing processes. Scanway is attempting to make both businesses more scalable through standardised product families, shared components and the HYDRA software platform. In the longer term, management also intends to participate further along the optical-data chain, moving from acquisition toward processing, analytics, prediction and potentially Data-as-a-Service.
Competitive Positioning
Scanway is one of the few publicly listed European small-cap companies focused specifically on optical payload integration. It describes itself as Poland's first commercial supplier of spectral instruments for space and has obtained flight heritage through missions including STAR VIBE, Ariane 6-related equipment and Polish satellite projects. Its positioning is based on combining optics, electronics, embedded processing and proprietary software in compact, cost-competitive systems. The company has progressed from relatively small instruments toward telescopes with apertures of approximately 200–450 mm and sub-one-metre imaging ambitions. Participation in ESA projects, lunar missions and international constellations provides technological validation that smaller suppliers often lack. However, Scanway remains much smaller than established European aerospace and optical groups. It must prove that its technology can be manufactured repeatedly, delivered on time and operated reliably in orbit. The appearance of Safran as an additional supplier to Marble Imaging also demonstrates that customers may use several vendors and that successful development work does not guarantee a dominant share of future constellation orders.
Economics & Capital Allocation
Under IFRS, Scanway Group generated PLN 21.36 million of revenue in FY2025, up from PLN 11.89 million in 2024. The operating loss was PLN 2.37 million and the net loss narrowed to PLN 0.71 million from PLN 2.58 million. Operating cash flow improved to positive PLN 3.41 million, while PLN 4.64 million was spent on property, equipment and intangible assets. An equity issue was the main reason year-end cash increased to PLN 25.52 million and equity rose to PLN 44.24 million. In Q1 2026, revenue increased by 29% year over year to PLN 3.77 million, but EBITDA was negative PLN 3.11 million and the net loss reached PLN 4.10 million. Operating costs increased rapidly as the company purchased materials for future project milestones, expanded employment and invested in infrastructure. Cash declined to PLN 13.48 million by 31 March 2026 after negative operating cash flow, investment expenditure and lease payments. The backlog reported on 28 May 2026 was PLN 53.52 million, of which PLN 52.86 million related to Space and only PLN 0.66 million to Industry. This provides material revenue visibility, but backlog is not equivalent to profit or cash: margins, milestone timing, execution costs and customer acceptance will determine its economic value.
Scanway is allocating capital primarily to engineering capacity, specialist employees, production and integration facilities, laboratory equipment, product development and working capital for larger optical payload contracts. In 2025, it raised approximately PLN 26 million of equity capital, including a strategic investment associated with TFI PZU, which materially strengthened the balance sheet. The proceeds helped fund development expenditure and the expansion required for larger telescopes and serial production. The company had no material conventional bank debt at the end of 2025, although it carried lease liabilities. Management initially indicated that no new issue was required for the transfer to the GPW Main Market. Subsequent discussion of projects awaiting formalisation and a pipeline materially larger than the existing balance sheet led to proposals giving the management board authority to increase share capital. This reflects the central capital-allocation trade-off: investing early may allow Scanway to capture a rapidly expanding order pipeline, but equity raised before the company achieves sustained profitability may dilute existing shareholders. Dividends are not a realistic near-term priority while the company is still scaling capacity and generating accounting losses.
Long-term Risks
The investment case assumes that Scanway can transform from a project-oriented engineering company into a repeatable manufacturer and integrator of optical payloads. This transition is operationally difficult. Space hardware has long qualification cycles, low tolerance for failure and limited opportunities for repair after launch. Costs can be incurred long before milestone payments, and revenue may shift materially between quarters when testing, acceptance or launch schedules move. The backlog is encouraging but concentrated almost entirely in Space, making the company dependent on a limited number of international programmes and customers. The Industry business has not yet demonstrated that HYDRA can create a material, recurring and less cyclical revenue stream. Investor discussions also show that expectations embedded in the share price may run ahead of reported profitability and cash generation. The company may therefore need to deliver rapid revenue growth while simultaneously preserving quality, project margins and liquidity. Failure in any one of these areas could require additional capital at unattractive terms. Additional risks arise from capitalised development expenditure, specialised personnel, supply-chain dependencies, foreign currencies, export restrictions and the possibility that larger competitors win commercial constellation orders after Scanway has funded early-stage development.
What Would Break the Thesis
- Backlog fails to convert into meaningful revenue during 2026–2027 because of repeated project or customer delays
- Major constellation customers select competing suppliers for serial production after Scanway completes development work
- A material Scanway instrument fails during qualification, launch, commissioning or orbital operation
- Production scaling results in persistent cost overruns, missed deadlines or deterioration in product quality
- Gross project margins remain insufficient to cover the expanded engineering, administrative and infrastructure cost base
- The company continues generating substantial EBITDA and cash losses despite rapid backlog growth
- Cash falls to a level requiring repeated dilutive equity issues before operating cash flow becomes structurally positive
- The Space segment remains dependent on a small number of customers or programmes without sufficient geographic and contractual diversification
- The Industry segment and HYDRA platform fail to gain commercial traction or generate repeatable revenue
- Large projects awaiting formalisation do not become binding contracts or are concluded on unattractive payment and margin terms
- The company fails to achieve reliable serial production of larger optical payloads
- Capitalised development costs require material impairment because the underlying products are not commercialised
- Loss of key engineers or management materially delays development and contract execution
- ESA, defence or sovereign-space expenditure is reduced or projects important to Scanway are cancelled
- Scanway does not establish a defensible position against larger European optical and aerospace competitors
Contracts Intelligence
Subscriber Content: Revenue allocations for future quarters are hidden. All contract allocations are available to subscribers. Subscribe or sign in to see the full data.
Currency Note: All amounts in PLN. Foreign currency contracts converted at announcement date rates.
| Contract | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue per Quarter | 1,234,567.89 | 1,234,567.89 | 1,234,567.89 | 1,234,567.89 | 1,234,567.89 | 1,234,567.89 | 1,234,567.89 | 1,234,567.89 | 1,234,567.89 | 1,234,567.89 | 77,603,811.74 |
|
Delivery of two optical Earth observation instruments for methane detection (NarSha project)
|
5,556,096.00 | ||||||||||
|
ScyLab SWIR Telescope and DPU Development Agreement (Scanway – KP Labs for ESA)
|
3,537,670.52 | ||||||||||
|
Phase A contract for the Mani project with University of Copenhagen
|
347,256.00 | ||||||||||
|
Delivery of three Earth observation telescopes to EnduroSat
|
3,176,121.96 | ||||||||||
|
Execution Agreement for CAMILA Project - Delivery of Two Optical Earth Observation Telescopes
|
14,237,500.00 | ||||||||||
|
Delivery of vision inspection system for satellite mirror deployment
|
304,608.00 | ||||||||||
|
Delivery of high-resolution optical telescopes for an Earth observation satellite constellation
|
38,430,000.00 | ||||||||||
|
Delivery of vision system for satellite docking inspection
|
225,716.40 | ||||||||||
|
Development of European Lunar Surface Imagery Processing System for ESA
|
1,688,050.02 | ||||||||||
|
SEMOViS ESA Project - Instrument Delivery and Development (addendum with Marble Imaging GmbH)
|
9,941,986.72 | ||||||||||
|
Mani Project Phase A Agreement with University of Copenhagen
|
158,806.12 |
AI-Generated Revenue Allocation: Revenue allocations follow IFRS 15 principles with AI-derived timing assumptions. Verify with official financial statements.
Financial Performance
Quarterly Data
Click a metric row to chart it below. Click a second row to overlay it on a dual axis; click a selected row again to remove it.
| Metric | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement Revenue (Quarterly) | 1.3M | 3.8M | 3.1M | 7.7M | 3.9M | 8.4M | 4.3M | 17.0M | 3.8M |
| Income Statement Gross Profit (Quarterly) | -1.2M | 1.1M | -519.6K | -1.4M | -1.4M | 7.3M | 0 | -2.4M | -4.2M |
| Income Statement EBITDA (Quarterly) | -934.1K | 1.5M | -221.1K | -478.5K | -204.7K | 4.7M | -1.3M | 2.2M | -3.1M |
| Income Statement EBIT (Quarterly) | -1.1M | 1.2M | -471.0K | -1.0M | -1.1M | 3.7M | -2.2M | -120.0K | -4.2M |
| Income Statement Net Income (Quarterly) | -1.2M | 1.2M | -487.3K | -1.3M | -1.1M | 3.7M | -2.3M | 1.6M | -4.1M |
| Costs Selling & Distribution Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Costs Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Costs Administrative Expenses (LTM) | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow Operating Cash Flow | -2.8M | 1.4M | 1.2M | -1.5M | 554.2K | 0 | 0 | 3.4M | -8.9M |
| Cash Flow Capital Expenditure | -1.1M | -1.5M | -1.1M | -1.1M | -1.4M | 0 | 0 | -4.7M | -2.6M |
| Cash Flow Free Cash Flow | -3.9M | -157.4K | 123.3K | -2.5M | -875.6K | - | - | -1.3M | -11.5M |
| Cash Flow Depreciation & Amortization | 193.3K | 288.6K | 249.9K | 553.5K | 930.7K | 940.0K | 0 | 3.3M | 1.1M |
| LTM Metrics Revenue (LTM) | - | - | - | 15.9M | 18.5M | 23.2M | 24.4M | 33.7M | 33.6M |
| LTM Metrics EBITDA (LTM) | - | - | - | -181.6K | 547.8K | 3.8M | 2.7M | 5.4M | 2.5M |
| LTM Metrics Net Income (LTM) | - | - | - | -1.8M | -1.8M | 774.0K | -998.7K | 1.8M | -1.1M |
| LTM Metrics Net Profit Attributable (LTM) | - | - | - | -1.8M | -1.8M | 774.0K | -998.7K | 1.8M | -1.1M |
| LTM Metrics Operating Cash Flow (LTM) | - | - | - | -1.7M | 1.7M | 303.8K | -903.5K | 4.0M | -5.5M |
| Profitability Gross Margin | -94.7% | 29.3% | -16.8% | -17.5% | -35.8% | 86.0% | 0.0% | -13.9% | -110.3% |
| Profitability EBITDA Margin | -74.5% | 38.5% | -7.1% | -6.2% | -5.3% | 55.3% | -29.2% | 13.2% | -82.5% |
| Profitability EBIT Margin | -89.9% | 30.8% | -15.2% | -13.3% | -29.2% | 44.2% | -51.7% | -0.7% | -110.3% |
| Profitability Net Margin | -92.3% | 30.7% | -15.7% | -16.6% | -29.4% | 43.7% | -52.0% | 9.1% | -108.8% |
| Profitability ROIC | -7.4% | 0.2% | -2.8% | -10.1% | -9.8% | 7.2% | -17.0% | 35.4% | -11.3% |
| Profitability Cash Conversion | 244.0% | 119.0% | -248.0% | 113.0% | -48.0% | 0.0% | 0.0% | 220.0% | 218.0% |
| Balance Sheet Current Assets | 3.5M | 3.5M | 4.3M | 6.1M | 5.4M | 0 | 0 | 33.3M | 25.2M |
| Balance Sheet Current Liabilities | 1.2M | 806.6K | 2.6M | 2.7M | 3.8M | 0 | 0 | 8.5M | 5.9M |
| Balance Sheet Inventories | 530.6K | 502.6K | 321.9K | 1.1M | 690.7K | 0 | 0 | 3.0M | 3.5M |
| Balance Sheet Trade Receivables | 2.5M | 2.7M | 1.8M | 896.9K | 1.6M | 0 | 0 | 2.7M | 4.2M |
| Balance Sheet Trade Payables | 1.2M | 806.6K | 0 | 953.3K | 3.8M | 0 | 0 | 6.5M | 2.1M |
| Balance Sheet Total Equity | 15.6M | 16.8M | 16.3M | 18.7M | 17.6M | 0 | 0 | 44.2M | 40.1M |
| Balance Sheet Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.3M | 0 |
| Balance Sheet Cash & Equivalents | 483.0K | 315.6K | 438.9K | 1.1M | 266.8K | 0 | 14.7M | 25.5M | 13.5M |
| Balance Sheet Invested Capital | 15.1M | 16.5M | 15.8M | 17.6M | 17.3M | 0 | -14.7M | 21.0M | 26.7M |
| Balance Sheet Net Working Capital | 1.8M | 2.4M | 2.1M | 1.0M | -1.4M | 0 | 0 | -786.0K | 5.6M |
| Ratios Current Ratio | 2.85 | 4.35 | 1.67 | 2.32 | 1.42 | - | - | 3.91 | 4.25 |
| Ratios Net Working Capital to Revenue | 1.41 | 0.63 | 0.68 | 0.13 | -0.37 | 0.00 | 0.00 | -0.05 | 1.49 |
| Ratios Administrative Expenses as % of Revenue | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Ratios Days Inventory Outstanding (DIO) | 154 | 36 | 14 | 25 | 14 | 0.00 | 0.00 | 33 | 38 |
| Ratios Days Sales Outstanding (DSO) | 716 | 195 | 81 | 21 | 32 | 0.00 | 0.00 | 29 | 46 |
| Ratios Days Payables Outstanding (DPO) | 356 | 59 | 0.00 | 22 | 74 | 0.00 | 0.00 | 71 | 23 |
| Ratios Cash Conversion Cycle (days) | 514 | 173 | 95 | 24 | -28 | 0.00 | 0.00 | -8.50 | 61 |
Revenue (Quarterly) - Visual Analysis
Revenue (Quarterly) (PLN)
Growth Rates (QoQ% and YoY%)
Data Source: Financial data sourced from company filings and periodic reports. Values in PLN. Margins and ratios stored as decimals converted to percentages for display.
Recent News & Developments
Sentiment Analysis (Last 6 Months)
| Positive | 75% |
| Neutral | 25% |
| Negative | 0% |
Based on 4 articles
Scanway S.A. Reports Financial Growth in 2025 Amid Strategic Expansion
Scanway S.A., a leading Polish deep-tech company specializing in optical observation systems and machine-vision technologies, has reported a significant increase in revenues for 2025, reaching PLN 21.36 million, a 79.7% growth compared to 2024. This growth was driven by the company's strategic focus on its Space segment, which contributed PLN 19.4 million to total revenues, primarily through international contracts with clients such as Nara Space Technology, Intuitive Machines, and Ghalam LLP. The Industry segment also contributed PLN 1.87 million, with notable projects in the food processing and packaging sectors.
Despite the revenue growth, Scanway S.A. reported a net loss of PLN 710,000 for 2025, an improvement from the PLN 2.58 million loss in 2024. The company attributed the losses to increased operational costs, including higher amortization expenses due to the commercialization of completed R&D projects, and the implementation of an employee stock ownership plan (ESOP). The company also successfully raised PLN 26.9 million through equity issuance to support its growth initiatives.
In 2025, Scanway S.A. continued to invest heavily in R&D, with PLN 2.66 million allocated to ongoing projects such as the modular HYDRA system and advanced satellite optical payloads. The company also confirmed the successful deployment of its optical systems in the PIAST satellite constellation, launched in late 2025, marking a significant milestone in its Space segment.
Looking ahead, Scanway S.A. plans to expand its portfolio of optical technologies and strengthen its position in the global space and industrial markets. The company has also secured a new contract worth approximately USD 4.3 million with a U.S.-based client for the development of advanced Earth observation instruments.
Relevance to Scanway S.A. Company Profile
This article highlights Scanway S.A.'s strategic growth in its core business areas of Space and Industry, aligning with its mission to innovate in optical observation and machine-vision technologies.
Scanway S.A. Reports Record Growth in Q2 2025 Amid Major Space and Industry Contracts
Wrocław, Poland – August 2025: Polish deep-tech company Scanway S.A. has reported a record-breaking 120% year-on-year increase in total revenues for Q2 2025, reaching PLN 8.44 million. The growth was primarily driven by the company’s Space segment, which accounted for 94% of total revenues, with significant contributions from a landmark EUR 9 million contract with a leading South Asian space company for high-resolution Earth observation telescopes. This contract, the largest in Scanway’s history, is expected to be completed by 2027 and will significantly bolster the company’s position in the global space technology market.
Scanway also announced its participation in the European Space Agency’s (ESA) CAMILA project, the largest civilian satellite constellation initiative in Poland’s history. The company will supply telescopes for at least two optical satellites and contribute to data processing and satellite operations. Additionally, Scanway has secured a EUR 500,000 contract with ESA to develop a European data processing system for lunar multispectral imagery as part of the 2026 Intuitive Machines mission to the Moon. This project will leverage Scanway’s proprietary HYDRA technology, showcasing its versatility across both industrial and space applications.
In the Industry segment, Scanway continued the commercialization of its HYDRA technology, implementing it in high-quality control systems for leading companies such as Bunge Polska and Evrafish. The company also raised PLN 11.6 million through a successful public offering in June 2025, which will be used to expand production capabilities, particularly for larger optical instruments, and to strengthen its Space division. Furthermore, Scanway has undergone a rebranding initiative, unifying its Space and Industry divisions under a single corporate identity, and launched a new website to support its international expansion and upcoming IPO on the Warsaw Stock Exchange.
Despite these successes, Scanway faces risks related to its reliance on external funding, consortium-based projects, and public grants. The company remains focused on its strategic goals, including scaling its operations, expanding its presence in the defense sector, and advancing its capabilities in lunar exploration and satellite constellations.
Relevance to Scanway S.A. Business Profile
This article highlights Scanway S.A.'s significant achievements in both its Space and Industry segments, aligning with its core business of developing advanced optical observation systems and image-processing technologies for space and industrial applications.
Scanway S.A. Reports Strong Growth in Space Sector and Advances in Industry Solutions
Wrocław, Poland – November 2025: Scanway S.A., a leading Polish deep-tech company specializing in optical observation systems and machine-vision technologies, has reported a 39% year-on-year increase in total revenues for Q3 2025, reaching PLN 4.35 million. The growth was primarily driven by the Space segment, which contributed PLN 3.85 million, while the Industry segment accounted for PLN 0.50 million. Cumulatively, revenues for Q1-Q3 2025 rose by 89% year-on-year to PLN 15.97 million, with the Space segment generating PLN 14.63 million of this total.
Key achievements in the Space segment include the successful completion of flight tests for the NarSha project with Nara Space Technology, the initiation of the second phase of the SEMOViS project with Marble Imaging, and the signing of a contract with the European Space Agency (ESA) to develop a data processing system for lunar exploration. Additionally, Scanway delivered two optical instruments for the CAMILA project, Poland’s largest civil satellite constellation initiative, and contributed to the PIAST mission for the Polish Armed Forces by providing optical telescopes and image acquisition systems.
In the Industry segment, Scanway expanded its partnerships with Bunge Polska and Fabios Sp. z o.o., implementing advanced machine-vision systems for quality control in manufacturing. The company also developed six flagship applications based on its proprietary HYDRA technology, targeting industries such as packaging, meat processing, and tire manufacturing. HYDRA, which integrates machine learning and hyperspectral imaging, is being positioned for global expansion through a Software-as-a-Service (SaaS) model.
Despite the revenue growth, Scanway reported a net loss of PLN 2.26 million for Q3 2025, attributed to significant investments in organizational and infrastructure development to support its growing project portfolio. The company’s backlog reached PLN 58.3 million as of November 2025, a 25% increase from June 2025, driven by new contracts, including the CAMILA project valued at approximately EUR 3.55 million.
Looking ahead, Scanway has adopted a new strategic plan for 2026–2028, aiming to become one of Europe’s leading integrators of optical payloads. The strategy focuses on scaling operations, participating in global satellite constellations, developing high-resolution imaging instruments, and expanding its portfolio to cover the entire optical data value chain. The company also plans to strengthen its presence in the defense sector and deepen its involvement in lunar exploration and large-scale public space programs.
Scanway’s recent achievements, including its contributions to key space missions and advancements in industrial automation, align with its core expertise in optical observation systems, optoelectronics, and image-processing software. These developments underscore the company’s commitment to innovation and its strategic goal of becoming a global leader in optical technologies.
Scanway S.A. Reports Increased Revenues but Faces Operational Challenges in Q1 2026
Wrocław, Poland – May 28, 2026: Scanway S.A., a leading Polish deep-tech company specializing in optical observation systems and machine-vision technologies, has reported its financial results for the first quarter of 2026. The company achieved a 29% year-on-year increase in revenue, reaching PLN 3.77 million, driven by growth in its Space segment and international contracts with clients such as Nara Space Technology, Imagine Marble, and Space Inventor. However, the company recorded a net loss of PLN 4.1 million, primarily due to rising operational costs, including higher expenses for materials, energy, and employee benefits.
Key projects contributing to the revenue growth include the Camilla project and other initiatives in the New Space sector. The Industry segment also saw contributions from projects in the food and packaging industries. Despite these achievements, the company faced challenges such as increased amortization costs and inflationary pressures, partly influenced by geopolitical tensions in Ukraine and the Middle East.
Additionally, Scanway S.A. announced significant post-quarter developments, including a collaboration with Łukasiewicz – Institute of Aviation for environmental testing of optical instruments and its involvement in the Titan mission with Aethero, which integrates high-resolution imaging with real-time onboard data processing using AI.
Cash flow challenges were evident, with net cash outflows of PLN 12 million during the quarter, attributed to operational and investment activities. The company continues to rely on commercial contracts, shareholder contributions, and grants to finance its operations.
Relevance to Scanway S.A. Profile
This article is relevant as it highlights Scanway S.A.'s core business activities in optical technologies for space and industrial applications, showcasing its strategic growth in the Space segment and its efforts to scale operations despite financial challenges.
2026 EPS Estimates
- Backlog conversion is delayed, customers use competing suppliers for later constellation phases, milestone receipts arrive later than expected and rising materials, payroll and infrastructure costs keep EBITDA deeply negative
- Cash consumption forces a sizeable equity issue, one or more major projects experience technical or acceptance problems, Industry remains immaterial and capitalised development expenditure requires impairment
- The supplied materials do not contain management profit guidance or enough contract-level margin and milestone information to produce a reliable forward EPS estimate
- A reasonable base case assumes that most of the PLN 53.52 million backlog is recognised during 2026–2027, revenue continues to grow strongly but unevenly, production expansion proceeds without major delays, Space remains the principal revenue source and EBITDA gradually improves as the existing cost base is absorbed
- The case also assumes that Scanway retains sufficient liquidity, although a moderate capital increase may be required to finance projects added to the current backlog
- Projects awaiting formalisation become binding contracts, the company wins repeat constellation orders, Intuitive Machines and Mani lead to additional lunar instruments, the 450 mm telescope platform is successfully commercialised, and production capacity expands to several or more than ten payloads annually
- Revenue grows faster than fixed costs, project margins improve, HYDRA generates material recurring or repeat business, and operating cash flow turns sustainably positive without significant shareholder dilution
Note: EPS estimates are for informational purposes only and represent our analytical framework, not investment recommendations. These financial results estimates are based on stated assumptions and may change as new information becomes available.
Key Metrics
Company-specific performance indicators tailored to Scanway S.A.'s business model.
No key metrics available yet
Custom performance indicators for Scanway S.A. will appear here once available.
Examples of metrics we track:
Data Source: Key metrics are extracted from company disclosures, periodic reports, and management commentary.
Periodic Report Publication Calendar
No report publication schedule available yet for this company.